Tharmaseelan H, Sgonina LM, Bühnen I, Schnetzke U, Meißner J, Sellmayr M, Beverungen D, Hellmuth JC, Puthenparambil J, Zamrik T, Ferdinandus J, Shumilov E, Kerkhoff A, Melchardt T, Bröckelmann PJ, Kobe C, Borchmann P, von Tresckow B. Anti–programmed cell death protein 1–based salvage therapy for relapsed/refractory Hodgkin lymphoma: a multicenter real-world analysis. haematol [Internet]. 2020Sep.10 [cited 2026Mar.4];. Available from: https://haematologica.org/article/view/13178